Infectious Disease PractitionerMaraviroc, metformin fail to control NAFLD in people with HIVNovember 5, 2021HIV
Infectious Disease PractitionerHIV prescription mandate controversy reaches the Supreme CourtNovember 5, 2021HIV
Infectious Disease PractitionerWithout PrEP, a third of new HIV cases occur in MSM at low riskNovember 1, 2021HIV
Infectious Disease PractitionerLong-acting HIV ART: Lessons from a year of CabenuvaNovember 1, 2021HIV
Infectious Disease PractitionerANCHOR study findings may usher in new care standards for anal cancer in HIV-infected patientsOctober 28, 2021HIV
Infectious Disease PractitionerFDA expands use of HIV drug to young childrenOctober 19, 2021HIVPediatrics
Infectious Disease PractitionerUpdates to CDC’s STI guidelines relevant to midlife women tooSeptember 27, 2021STIsHIV
Infectious Disease PractitionerOne in six HIV PrEP Descovy switches contraindicatedSeptember 24, 2021HIV
Infectious Disease PractitionerCOVID-19 causes major interruption in global HIV progressSeptember 22, 2021HIVTuberculosis
Infectious Disease PractitionerNIH on HIV vaccine failure: ‘Get your HIV-negative, at-risk patients on PrEP tomorrow’September 7, 2021HIV
Infectious Disease PractitionerTB prevention in people with HIV: How short can we go?August 27, 2021HIVPulmonary Infections
Infectious Disease PractitionerStudy: More than half of people taking HIV PrEP discontinue useAugust 26, 2021HIV
Infectious Disease PractitionerInjectable cabotegravir PrEP superior to oral TDF-FTC; trial halted earlyAugust 12, 2021HIV
Infectious Disease PractitionerNew guideline for replacement ART: CAB/RPV LA not for everyoneAugust 5, 2021HIV
Infectious Disease PractitionerImmune reconstitution inflammatory syndrome: ‘Why is my patient getting worse?’July 29, 2021HIV
